Adaptive Biotechnologies (ADPT) Other Non-Current Assets (2018 - 2025)
Adaptive Biotechnologies' Other Non-Current Assets history spans 8 years, with the latest figure at $1.2 million for Q4 2025.
- For Q4 2025, Other Non-Current Assets fell 58.34% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, down 58.34%, while the annual FY2025 figure was $1.2 million, 58.34% down from the prior year.
- Other Non-Current Assets for Q4 2025 was $1.2 million at Adaptive Biotechnologies, down from $1.8 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.6 million in Q4 2023 and bottomed at $778000.0 in Q2 2022.
- The 5-year median for Other Non-Current Assets is $2.4 million (2022), against an average of $2.4 million.
- The largest annual shift saw Other Non-Current Assets crashed 62.95% in 2022 before it surged 330.85% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $2.1 million in 2021, then fell by 1.71% to $2.1 million in 2022, then surged by 73.98% to $3.6 million in 2023, then fell by 19.33% to $2.9 million in 2024, then tumbled by 58.34% to $1.2 million in 2025.
- Per Business Quant, the three most recent readings for ADPT's Other Non-Current Assets are $1.2 million (Q4 2025), $1.8 million (Q3 2025), and $2.7 million (Q2 2025).